CSRNP3 anticorps (N-Term)

N° du produit ABIN951714

Détail du produit anti-CSRNP3 anticorps

Antigène: CSRNP3 (Cysteine-Serine-Rich Nuclear Protein 3 (CSRNP3))

Épitope: AA 35-64, N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CSRNP3 est non-conjugé

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Specificité: This antibody reacts to CSRNP3.

Réactivité croisée (Details): Species reactivity (tested):Human.

Purification: Affinity chromatography on Protein A

Immunogène: KLH conjugated synthetic peptide between 35-64 amino acids from the N-terminal region of human CSRNP3

Isotype: Ig Fraction

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS, 0.09 % (W/V) sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détails sur CSRNP3

Antigène: CSRNP3 (Cysteine-Serine-Rich Nuclear Protein 3 (CSRNP3))

Autre désignation: CSRNP3 / TAIP2 (CSRNP3 Produits)

Synonymes: anticorps FAM130A2, anticorps PPP1R73, anticorps TAIP-2, anticorps TAIP2, anticorps A330102K23Rik, anticorps CSRNP-3, anticorps Csnrp3, anticorps Mbu1, anticorps taip-2, anticorps cysteine and serine rich nuclear protein 3, anticorps cysteine-serine-rich nuclear protein 3, anticorps CSRNP3, anticorps Csrnp3

Sujet: CSRNP3 binds to the consensus sequence 5'-AGAGTG-3' and has transcriptional activator activity. Plays a role in apoptosis (By similarity).Synonyms: CSRNP-3, Cysteine/serine-rich nuclear protein 3, FAM130A2, TAIP-2, TGF-beta-induced apoptosis protein 2

Poids moléculaire: 64900 Da

ID gène: 80034

NCBI Accession: NP_001165644